JP2023524812A5 - - Google Patents
Info
- Publication number
- JP2023524812A5 JP2023524812A5 JP2022567560A JP2022567560A JP2023524812A5 JP 2023524812 A5 JP2023524812 A5 JP 2023524812A5 JP 2022567560 A JP2022567560 A JP 2022567560A JP 2022567560 A JP2022567560 A JP 2022567560A JP 2023524812 A5 JP2023524812 A5 JP 2023524812A5
- Authority
- JP
- Japan
- Prior art keywords
- linker compound
- alkyl
- independently
- present
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063022313P | 2020-05-08 | 2020-05-08 | |
| US63/022,313 | 2020-05-08 | ||
| PCT/US2021/031287 WO2021226454A1 (en) | 2020-05-08 | 2021-05-07 | Linker compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023524812A JP2023524812A (ja) | 2023-06-13 |
| JP2023524812A5 true JP2023524812A5 (cg-RX-API-DMAC7.html) | 2024-05-14 |
Family
ID=78468445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022567560A Pending JP2023524812A (ja) | 2020-05-08 | 2021-05-07 | リンカー化合物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230201358A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4146280A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023524812A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021226454A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120500355A (zh) * | 2022-08-17 | 2025-08-15 | 隆萨销售股份有限公司 | 包含生物活性分子和细胞穿透肽可裂解接头的细胞外囊泡 |
| EP4572802A1 (en) * | 2022-08-17 | 2025-06-25 | Lonza Sales AG | Extracellular vesicle comprising a biologically active molecule and a dual cleavable linker |
| EP4572801A1 (en) * | 2022-08-17 | 2025-06-25 | Lonza Sales AG | Extracellular vesicle comprising a biologically active molecule and a cleavable linker |
| WO2025157273A1 (en) * | 2024-01-25 | 2025-07-31 | Shanghai Rona Therapeutics Co., Ltd. | Two or more nucleic acid molecules connected by a linker |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5916750A (en) * | 1997-01-08 | 1999-06-29 | Biogenex Laboratories | Multifunctional linking reagents for synthesis of branched oligomers |
| RU2013117288A (ru) * | 2010-12-17 | 2015-01-27 | Эрроухэд Рисерч Корпорейшн | СОДЕРЖАЩАЯ ГАЛАКТОЗНЫЙ КЛАСТЕР НАЦЕЛИВАЮЩАЯ ГРУППА ДЛЯ миРНК, МОДУЛИРУЮЩАЯ ФОРМАКОКИНЕТИЧЕСКИЕ СВОЙСТВА |
| CN104822656B (zh) * | 2012-05-15 | 2018-05-01 | 西雅图基因公司 | 自稳定接头偶联物 |
| WO2015085142A1 (en) * | 2013-12-05 | 2015-06-11 | New England Biolabs, Inc. | Compositions and methods for capping rna |
| US9988454B2 (en) * | 2015-05-20 | 2018-06-05 | Immunwork Inc. | Peptide core-based multi-arm linkers for treating central nervous system diseases |
| AU2019315593B2 (en) * | 2018-08-02 | 2026-05-21 | Dyne Therapeutics, Inc. | Muscle-targeting complexes and uses thereof |
-
2021
- 2021-05-07 WO PCT/US2021/031287 patent/WO2021226454A1/en not_active Ceased
- 2021-05-07 EP EP21799520.8A patent/EP4146280A4/en active Pending
- 2021-05-07 JP JP2022567560A patent/JP2023524812A/ja active Pending
- 2021-05-07 US US17/923,843 patent/US20230201358A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5756710A (en) | Phosphorothioate oligonucleotides that bind to the V3-loop and uses thereof | |
| TWI823866B (zh) | 用於抑制類血管生成素蛋白-3(ANGPTL3)表現的RNAi藥劑及組合物及使用方法 | |
| TWI784934B (zh) | 抑制lpa之基因表現之組合物及方法 | |
| JP5650367B2 (ja) | 医薬組成物 | |
| CN110832077B (zh) | 用于抑制α-ENaC表达的RNAi剂及使用方法 | |
| US6365345B1 (en) | Antisense nucleic acids for the prevention and treatment of disorders in which expression of c-erbB plays a role | |
| TW202307207A (zh) | 用於抑制黃嘌呤脫氫酶(XDH)之表現之RNAi藥劑、其醫藥組合物及使用方法 | |
| JP7830340B2 (ja) | PNPLA3の発現を阻害するためのRNAi薬、その医薬組成物、及び使用方法 | |
| JP2023537798A5 (cg-RX-API-DMAC7.html) | ||
| HUE035799T2 (en) | Cationic oligonucleotide analogues containing subunits | |
| JPH09504297A (ja) | 2′−アミドおよび2′−ペプチド修飾オリゴヌクレオチド | |
| JP7777522B2 (ja) | ベータENaCの発現を阻害するRNAi剤、その組成物および使用方法 | |
| JP2008512097A (ja) | アプタマー医薬品化学 | |
| TW202227135A (zh) | 用於遞送治療劑之脂質結合物 | |
| EP4653532A2 (en) | Advanced rna targeting (arnatar) | |
| US20200248177A1 (en) | Small guide antisense nucleic acid and use thereof | |
| TW202304474A (zh) | 用於抑制晚期糖化終產物之受體表現之RNAi藥劑、其組合物及使用方法 | |
| JP2023526210A (ja) | 直交性に連結された多量体オリゴヌクレオチド | |
| CN104321334A (zh) | 三环核苷及由其制备的低聚化合物 | |
| CN111212909A (zh) | 用于抑制去唾液酸糖蛋白受体1的表达的RNAi试剂和组合物 | |
| JP2024520555A5 (cg-RX-API-DMAC7.html) | ||
| JP2024541701A5 (cg-RX-API-DMAC7.html) | ||
| TW202218687A (zh) | 骨骼肌遞送載體及其使用方法 | |
| WO2020178258A1 (en) | Intracellular targeting of molecules | |
| WO2025240884A1 (en) | Patterned modified oligonucleotides |